Veloxis Pharmaceuticals, Inc. v. United States Food and Drug Administration

How courts have described this case

Verbatim parenthetical descriptions written by other courts when citing this decision. Ranked by citation-network relevance.

• observing that the parties \essentially concede[d] that [conditions of approval] is ambiguous\ and proceeding to Chevron Step Two
• denying motion to supplement record with meeting minutes, in part, because they were “cumulative”
• \Because the parties agree that the term 'conditions of approval' is undefined in the FDCA and that no FDA implementing regulation clarifies the meaning of that term ... the parties essentially concede that the term is ambiguous.\
• “Because the parties agree that the term ‘conditions of approval’ is undefined in the FDCA and that no FDA implementing regulation clarifies the meaning of that term . . . the parties essentially concede that the term is ambiguous.”

Source: CourtListener parenthetical corpus (CC0).